Two Seas Capital LP Roivant Sciences Ltd. Transaction History
Two Seas Capital LP
- $5.37 Billion
- Q2 2025
A detailed history of Two Seas Capital LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Two Seas Capital LP holds 10,598,040 shares of ROIV stock, worth $123 Million. This represents 2.22% of its overall portfolio holdings.
Number of Shares
10,598,040
Previous 10,136,307
4.56%
Holding current value
$123 Million
Previous $102 Million
16.78%
% of portfolio
2.22%
Previous 3.67%
Shares
15 transactions
Others Institutions Holding ROIV
# of Institutions
361Shares Held
456MCall Options Held
8.34MPut Options Held
720K-
Sb Investment Advisers (Uk) LTD London, X060MShares$694 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$517 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$455 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$396 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...